fk 3311 has been researched along with thromboxane a2 in 1 studies
| Studies (fk 3311) | Trials (fk 3311) | Recent Studies (post-2010) (fk 3311) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, K; Morishita, Y; Ohwada, S; Oriuchi, N; Sunose, Y; Takeyoshi, I; Tsutsumi, H | 1 |
1 other study(ies) available for fk 3311 and thromboxane a2
| Article | Year |
|---|---|
Effect of a cyclooxygenase-2 inhibitor, FK3311, in a canine lung transplantation model.
Topics: Anilides; Animals; Cyclooxygenase Inhibitors; Dogs; Hemodynamics; Lung; Lung Transplantation; Pulmonary Gas Exchange; Reperfusion Injury; Thromboxane A2; Thromboxane B2 | 2001 |